Title of article :
Standardized Herbal PM014 Formula Ameliorates Pulmonary Fibrosis in COVID-19 Patients by Inhibiting the TGF-β1 Signaling Pathway
Author/Authors :
Allahverdi-Khani ، Maryam Clinical Research Development Center - Islamic Azad University, Najafabad Branch , Ulloa ، Luis Dept. of Anesthesiology - Center for Perioperative Organ Protection - Duke University , Motaghinejad ، Majid Chronic Respiratory Disease Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD) - Shahid Beheshti University of Medical Sciences , Salehirad ، Mahsa Cognitive and Neuroscience Research Center (CNRC), Amir-Almomenin Hospital - Islamic Azad University, Tehran Medical Sciences
Abstract :
A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.
Keywords :
COVID , 19 , Anti , inflammatory , Plant , derived , Pulmonary fibrosis
Journal title :
Journal of Advances in Medical and Biomedical Research
Journal title :
Journal of Advances in Medical and Biomedical Research
